The Real GEROVITAL GH3 Dr Ana Aslan from ROMANIA

The authentic GEROVITAL H3 Dr Ana Aslan

it is made only in ROMANIA 

For questions regarding authenticity of GEROVITAL H3 

Dr Ana Aslan anti aging treatment, contact

supplier Alexandru Calin (Phd in Chemistry)
VAT: RO40837257

Bucharest, Romania, Europe.

Phone: +40723141550 (whatsapp/viber/telegram) 

E-mail: sales@gerovital-gh3.com

Secondary E-mail: order.gerovital@gmail.com

Payments accepted:

1. Secure Bank Transfer Wire

2. Transferwise

3. Western Union Online

Gerovital® H 3 Injections

One vial of 5 ml solution for injection contains 100 mg procaine hydrochloride, 6 mg benzoic acid, 0.5 mg disodium phosphate dodecahydrate, 5 mg potassium metabisulfite, and excipients: water for injections.

Gerovital® H 3 Tablets One tablet contains 100 mg procaine hydrochloride, 6 mg benzoic acid, 0.5 mg disodium phosphate dodecahydrate, 5 mg potassium metabisulphite and excipients: core: corn starch, mannitol, gelatin, talc, vegetable magnesium stearate; Dragee layer: sugar, talc, polyvidone K30, sodium carboxymethylcellulose, colloidal silicon dioxide, polysorbate 80, titanium dioxide, shellack, Carnauba powder wax.

PHARMACOTERAPEUTICAL GROUP: Tonics, combinations.

THERAPEUTICAL INDICATIONS
Useful in preventing aging phenomena;
Used in:
• Mild-moderate depression, especially when conventional therapy is not well tolerated or contraindicated;
• Parkinsonian syndromes - alone or in combination with antiparkinsonian drugs, especially dopaminergic agents;
• Chronic degenerative rheumatism;
• Systemic atherosclerosis accompanied by hypercholesterolemia, ischemic cardiopathy, arteritis, cerebral atherosclerosis

Interactions
Gerovital® H 3 should not be administered simultaneously with:

• sulphamides (antagonist mechanism of action) - except for antidiabetic agents;
• anticolinesterase: neostigmine, ezerine (physostigmine) and pyridostigmine.

SPECIAL WARNINGS

It is not recommended to use the product during pregnancy and breast-feeding.

DOSES AND METHOD OF ADMINISTRATIONInjections: The recommended dose is 5 ml (1 vial) of  

Gerovital® H 3 intramuscular injection 3 times a week (1 vial of Gerovital® H 3 solution every two days) for 4 weeks.

Tablets: The recommended dose is 2 Gerovital® H 3 tablets daily, after meals, in the morning and in the afternoon for 24 days.
The treatment series will be followed annually, continuously or with a one-month rest period between them. The schedule and frequency of breaks will be decided by the geriatric physician, depending on the patient's condition.

Depressive syndrome:

In the first week, the recommended dose is 5 ml (1 ampoule) of Gerovital® H 3 injection daily, intramuscularly, 3 times a week (for example, Monday, Wednesday and Friday);
Week two and third: the recommended dose is 7.5 ml (1 ½ ampoules) of Gerovital® H 3 injection daily, intramuscularly, 3 times per week.
In the fourth week: the recommended dose is 10 ml (2 ampoules) of Gerovital® H 3 solution for injection daily, intramuscularly 3 times a week.
Treatment should be repeated 4-6 times a year.

Parkinsonian syndromes:

The recommended dose is 5 ml (1 ampoule) of Gerovital® H 3 solution for injection, intramuscularly and 2 Gerovital® H 3 tablets daily for 15 days.

Degenerative chronic rheumatism:

The recommended dose is 5 ml (1 ampoule) Gerovital solution for injection